No Matches Found
No Matches Found
No Matches Found
Shenzhen Weiguang Biological Products Co., Ltd.
Shenzhen Weiguang Biological Faces Evaluation Shift Amid Bearish Technical Indicators
Shenzhen Weiguang Biological Products Co., Ltd. has experienced a recent evaluation adjustment, influenced by bearish technical indicators. Financial results for the quarter ending September 2025 show challenges, including decreased net sales and operating cash flow, alongside a decline in stock performance relative to the China Shanghai Composite index.
Shenzhen Weiguang Biological Hits Day Low at CNY 25.83 Amid Price Pressure
Shenzhen Weiguang Biological Products Co., Ltd. saw a notable stock decline, contrasting with the broader market's performance. The company reported a significant drop in net sales and operating cash flow, while its year-to-date gains remain modest compared to the overall market. Its market capitalization is CNY 6,997 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
